The Supreme Court tackles patents
The US Supreme Court is in session again and there are two patent cases up for review. First up is MedImmune v Genentech, which essentially deals with current US practice that states a licensee cannot challenge the validity of a licensor’s patent in…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.